Marata, Jezel Jane B.
HRN: 23-82-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2023
CEFUROXIME 1.5GM (VIAL)
10/01/2023
10/07/2023
IV
1.5 G
Q8
UTI, Preterm Labor
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes